• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗凝和抗血小板药物对创伤患者手术率和死亡率的影响。

Impact of anticoagulation and antiplatelet drugs on surgery rates and mortality in trauma patients.

机构信息

Department of Trauma and Reconstructive Surgery, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.

Department of Surgical Intensive Care, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.

出版信息

Sci Rep. 2021 Jul 26;11(1):15172. doi: 10.1038/s41598-021-94675-7.

DOI:10.1038/s41598-021-94675-7
PMID:34312424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8313576/
Abstract

Preinjury anticoagulation therapy (AT) is associated with a higher risk for major bleeding. We aimed to evaluated the influence of preinjury anticoagulant medication on the clinical course after moderate and severe trauma. Patients in the TraumaRegister DGU ≥ 55 years who received AT were matched with patients not receiving AT. Pairs were grouped according to the drug used: Antiplatelet drugs (APD), vitamin K antagonists (VKA) and direct oral anticoagulants (DOAC). The primary end points were early (< 24 h) and total in-hospital mortality. Secondary endpoints included emergency surgical procedure rates and surgery rates. The APD group matched 1759 pairs, the VKA group 677 pairs, and the DOAC group 437 pairs. Surgery rates were statistically significant higher in the AT groups compared to controls (APD group: 51.8% vs. 47.8%, p = 0.015; VKA group: 52.4% vs. 44.8%, p = 0.005; DOAC group: 52.6% vs. 41.0%, p = 0.001). Patients on VKA had higher total in-hospital mortality (23.9% vs. 19.5%, p = 0.026), whereas APD patients showed a significantly higher early mortality compared to controls (5.3% vs. 3.5%, p = 0.011). Standard operating procedures should be developed to avoid lethal under-triage. Further studies should focus on detailed information about complications, secondary surgical procedures and preventable risk factors in relation to mortality.

摘要

受伤前抗凝治疗(AT)与大出血风险增加相关。我们旨在评估受伤前抗凝药物对中重度创伤后临床病程的影响。在 TraumaRegister DGU ≥ 55 岁且接受 AT 的患者中,与未接受 AT 的患者进行匹配。根据使用的药物将患者分为抗血小板药物(APD)、维生素 K 拮抗剂(VKA)和直接口服抗凝剂(DOAC)组。主要终点为早期(<24 小时)和总住院死亡率。次要终点包括急诊手术率和手术率。APD 组匹配了 1759 对,VKA 组匹配了 677 对,DOAC 组匹配了 437 对。与对照组相比,AT 组的手术率明显更高(APD 组:51.8%比 47.8%,p=0.015;VKA 组:52.4%比 44.8%,p=0.005;DOAC 组:52.6%比 41.0%,p=0.001)。VKA 组总住院死亡率较高(23.9%比 19.5%,p=0.026),而 APD 患者的早期死亡率明显高于对照组(5.3%比 3.5%,p=0.011)。应制定标准操作程序以避免致命的分诊不足。进一步的研究应重点关注与死亡率相关的并发症、二次手术和可预防风险因素的详细信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c060/8313576/2496085b9d8b/41598_2021_94675_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c060/8313576/2496085b9d8b/41598_2021_94675_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c060/8313576/2496085b9d8b/41598_2021_94675_Fig1_HTML.jpg

相似文献

1
Impact of anticoagulation and antiplatelet drugs on surgery rates and mortality in trauma patients.抗凝和抗血小板药物对创伤患者手术率和死亡率的影响。
Sci Rep. 2021 Jul 26;11(1):15172. doi: 10.1038/s41598-021-94675-7.
2
Association of mortality among trauma patients taking preinjury direct oral anticoagulants versus vitamin K antagonists.创伤患者服用损伤前直接口服抗凝剂与维生素 K 拮抗剂的死亡率相关性。
Surgery. 2019 Oct;166(4):564-571. doi: 10.1016/j.surg.2019.04.039. Epub 2019 Aug 19.
3
Direct oral anticoagulants and cardiac surgery: A descriptive study of preoperative management and postoperative outcomes.直接口服抗凝剂与心脏手术:术前管理与术后结局的描述性研究。
J Thorac Cardiovasc Surg. 2021 May;161(5):1864-1874.e2. doi: 10.1016/j.jtcvs.2019.11.119. Epub 2019 Dec 17.
4
Comparison of direct oral anticoagulant and vitamin K antagonists on outcomes among elderly and nonelderly trauma patients.比较直接口服抗凝剂和维生素 K 拮抗剂在老年和非老年创伤患者结局中的应用。
J Trauma Acute Care Surg. 2020 Sep;89(3):514-522. doi: 10.1097/TA.0000000000002823.
5
Outcome of older hip fracture patients on anticoagulation: a comparison of vitamin K-antagonists and Factor Xa inhibitors.老年髋部骨折患者抗凝治疗的结局:维生素K拮抗剂与Xa因子抑制剂的比较。
Arch Orthop Trauma Surg. 2021 Apr;141(4):637-643. doi: 10.1007/s00402-020-03547-8. Epub 2020 Jul 24.
6
Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.达比加群或利伐沙班与维生素K拮抗剂新治疗的非瓣膜性心房颤动患者出血和动脉血栓栓塞事件短期风险的比较:一项法国全国性倾向匹配队列研究。
Circulation. 2015 Sep 29;132(13):1252-60. doi: 10.1161/CIRCULATIONAHA.115.015710. Epub 2015 Jul 21.
7
Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.在患有稳定型冠状动脉疾病和心房颤动的门诊患者中使用或不使用长期抗血小板治疗的维生素K拮抗剂:与缺血性和出血性事件的关联
Clin Cardiol. 2017 Oct;40(10):932-939. doi: 10.1002/clc.22750. Epub 2017 Jul 10.
8
Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair.二尖瓣修复术后抗血小板治疗与口服抗凝治疗作为抗血栓预防措施的比较
J Thorac Cardiovasc Surg. 2016 May;151(5):1302-8.e1. doi: 10.1016/j.jtcvs.2015.12.036. Epub 2016 Jan 5.
9
Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.急性冠状动脉综合征或经皮冠状动脉介入治疗后早期和晚期心房颤动患者抗栓治疗的风险/获益权衡:来自 AUGUSTUS 的见解。
Circulation. 2020 May 19;141(20):1618-1627. doi: 10.1161/CIRCULATIONAHA.120.046534. Epub 2020 Mar 29.
10
Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis.延长抗凝治疗用于静脉血栓栓塞事件的二级预防:一项更新的网络荟萃分析。
PLoS One. 2019 Apr 1;14(4):e0214134. doi: 10.1371/journal.pone.0214134. eCollection 2019.

引用本文的文献

1
Patterns of sex-specific outcomes and mortality in polytrauma: a demographic and epidemiologic analysis by injury severity score.多发伤中性别特异性结局与死亡率模式:基于损伤严重程度评分的人口统计学和流行病学分析
Eur J Trauma Emerg Surg. 2025 Jul 7;51(1):250. doi: 10.1007/s00068-025-02930-7.
2
Outcomes of trauma patients on chronic antithrombotic therapies in a trauma center in a rural state.农村地区一家创伤中心接受慢性抗血栓治疗的创伤患者的治疗结果。
Surg Pract Sci. 2023 Oct 4;15:100221. doi: 10.1016/j.sipas.2023.100221. eCollection 2023 Dec.
3
A Case Report of Extra-pericardial Tamponade From a Low-Level Fall.

本文引用的文献

1
Differences in the epidemiology of out-of-hospital and in-hospital trauma deaths.院外和院内创伤死亡的流行病学差异。
PLoS One. 2019 Jun 4;14(6):e0217158. doi: 10.1371/journal.pone.0217158. eCollection 2019.
2
Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities.年龄阈值用于非维生素 K 拮抗剂口服抗凝剂预防房颤患者卒中:深入了解最佳年龄评估和新发合并症。
Eur Heart J. 2019 May 14;40(19):1504-1514. doi: 10.1093/eurheartj/ehy837.
3
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care.
一例因轻度坠落导致的心外膜下填塞病例报告。
Cureus. 2024 Nov 16;16(11):e73824. doi: 10.7759/cureus.73824. eCollection 2024 Nov.
4
Management of factor Xa inhibitor-related traumatic non-intracranial bleeding events with andexanet alfa or four-factor prothrombin complex concentrate in a US multicenter observational study.在美国一项多中心观察性研究中,使用andexanet alfa或四因子凝血酶原复合物浓缩物治疗与Xa因子抑制剂相关的创伤性非颅内出血事件
J Am Coll Emerg Physicians Open. 2024 Nov 7;5(6):e13333. doi: 10.1002/emp2.13333. eCollection 2024 Dec.
5
Early Hip Fracture Surgery in Patients Taking Direct Oral Anticoagulants Improves Outcome.接受直接口服抗凝剂治疗的患者早期髋部骨折手术可改善预后。
J Clin Med. 2024 Aug 11;13(16):4707. doi: 10.3390/jcm13164707.
6
Is It Safe to Resume Direct Oral Anticoagulants upon Discharge after Hip Fracture Surgery? A Retrospective Study.髋部骨折手术后出院时恢复直接口服抗凝剂是否安全?一项回顾性研究。
J Clin Med. 2023 Dec 19;13(1):17. doi: 10.3390/jcm13010017.
7
Bilateral simultaneous knee arthroplasty shows comparable early outcome and complication rate as staged bilateral knee arthroplasty for patients scored ASA 1-3 if performed by a high-volume surgeon: a retrospective cohort study of 127 cases.对于 ASA 评分为 1-3 分的患者,如果由高容量外科医生进行手术,双侧同期膝关节置换术在早期结果和并发症发生率方面与分期双侧膝关节置换术相当:一项 127 例回顾性队列研究。
Arch Orthop Trauma Surg. 2024 Jan;144(1):417-424. doi: 10.1007/s00402-023-05078-4. Epub 2023 Oct 9.
8
Retrospective cohort study to determine the effect of preinjury antiplatelet or anticoagulant therapy on mortality in patients with major trauma.一项回顾性队列研究,以确定受伤前抗血小板或抗凝治疗对严重创伤患者死亡率的影响。
Front Med (Lausanne). 2023 Jan 9;9:1089219. doi: 10.3389/fmed.2022.1089219. eCollection 2022.
9
Does Antithrombotic Therapy Affect Outcomes in Major Trauma Patients? A Retrospective Cohort Study from a Tertiary Trauma Centre.抗血栓治疗对严重创伤患者的预后有何影响?一项来自三级创伤中心的回顾性队列研究。
J Clin Med. 2022 Sep 29;11(19):5764. doi: 10.3390/jcm11195764.
10
Treatment and outcomes of anticoagulated geriatric trauma patients with traumatic intracranial hemorrhage after falls.抗凝老年创伤患者跌倒后创伤性颅内出血的治疗和转归。
Eur J Trauma Emerg Surg. 2022 Oct;48(5):4297-4304. doi: 10.1007/s00068-022-01938-7. Epub 2022 Mar 10.
真实世界中直接口服抗凝剂与华法林的风险和获益比较:初级保健队列研究
BMJ. 2018 Oct 18;363:k4413. doi: 10.1136/bmj.k4413.
4
Recent progress and market analysis of anticoagulant drugs.抗凝药物的最新进展与市场分析
J Thorac Dis. 2018 Mar;10(3):2011-2025. doi: 10.21037/jtd.2018.03.95.
5
Should surgery be delayed in patients taking direct oral anticoagulants who suffer a hip fracture? A retrospective, case-controlled observational study at a UK major trauma centre.对于发生髋部骨折且正在服用直接口服抗凝剂的患者,手术是否应延期?英国一家主要创伤中心的一项回顾性病例对照观察研究。
BMJ Open. 2018 Apr 28;8(4):e020625. doi: 10.1136/bmjopen-2017-020625.
6
The updated German "Polytrauma - Guideline": an extensive literature evaluation and treatment recommendation for the care of the critically injured patient.最新版德国《多发伤指南》:对危重伤员护理的广泛文献评估与治疗建议
Eur J Trauma Emerg Surg. 2018 Apr;44(Suppl 1):1. doi: 10.1007/s00068-018-0949-0.
7
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.2018 年欧洲心脏病学会关于非维生素 K 拮抗剂口服抗凝剂在心房颤动患者中应用的实用指南。
Eur Heart J. 2018 Apr 21;39(16):1330-1393. doi: 10.1093/eurheartj/ehy136.
8
Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.服用非维生素K拮抗剂与维生素K拮抗剂口服抗凝剂的患者发生脑出血与院内死亡率的关联
JAMA. 2018 Feb 6;319(5):463-473. doi: 10.1001/jama.2017.21917.
9
Bleeding Complications After Use of Novel Oral Anticoagulants in Patients Undergoing Cardiac Surgery.新型口服抗凝剂在心脏手术患者中的出血并发症。
Ann Thorac Surg. 2018 Mar;105(3):702-708. doi: 10.1016/j.athoracsur.2017.11.066. Epub 2018 Jan 2.
10
Atrial fibrillation decision support tool: Population perspective.心房颤动决策支持工具:人群视角。
Am Heart J. 2017 Dec;194:49-60. doi: 10.1016/j.ahj.2017.08.016. Epub 2017 Aug 23.